Sanye Tablet Ameliorates Insulin Resistance and Dysregulated Lipid Metabolism in High-Fat Diet-Induced Obese Mice

Sanye Tablet (SYT) is a patent prescription widely used in treating T2D and pre-diabetes, especially T2D comorbid with hypertriglyceridemia, for many years in China. However, the underlying mechanism that accounts for the anti-diabetic potential of SYT by regulating lipid-related intermediates remai...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Minghe, Li, Lin, Huang, Ming, Tan, Yao, Shang, Ye, Meng, Xianghui, Pang, Yafen, Xu, Hong, Zhao, Xin, Lei, Wei, Chang, Yanxu, Wang, Yi, Zhang, Deqin, Zhang, Boli, Li, Yuhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511530/
https://www.ncbi.nlm.nih.gov/pubmed/34658856
http://dx.doi.org/10.3389/fphar.2021.713750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511530/
https://www.ncbi.nlm.nih.gov/pubmed/34658856
http://dx.doi.org/10.3389/fphar.2021.713750

Ejemplares similares